The San Raffaele Hospital in Milan has been ordered to suspend its embryology laboratory following a human error that resulted in the wrong embryo being implanted in a patient during a medically assisted reproduction procedure in July 2024. The Italian Ministry of Health and the ATS (Health Protection Agency) of Metropolitan Milan imposed the shutdown in early August, with the possibility of extension until all corrective measures are verified.
Why This Matters
• Patient safety breach: A woman received an embryo belonging to another couple due to protocol error during embryo transfer procedures.
• National regulatory response: The suspension can be extended until the hospital demonstrates compliance with safety protocols.
• System-wide debate: The incident has reignited calls to make electronic witnessing systems mandatory across all fertility clinics in Italy.
The Error and Immediate Response
According to hospital reports, the mistake occurred when medical staff incorrectly identified the patient during embryo transfer procedures at the San Raffaele's Level III Assisted Reproduction Center. The embryo intended for one couple was implanted in another patient's cycle. The woman who received the incorrect embryo was immediately informed and given appropriate medical support and options.
The San Raffaele Hospital issued a statement expressing "profound regret" for the incident and confirmed it is providing full support to both couples involved. Hospital administrators have launched an internal investigation to determine how the protocol breakdown occurred despite existing safety measures.
What This Means for Fertility Patients in Italy
The suspension affects all embryology operations at one of Milan's most prominent fertility centers, forcing dozens of couples to postpone or relocate their treatment cycles. Patients scheduled for procedures during the suspension period have been redirected to other accredited facilities across Lombardy and neighboring regions.
Beyond the immediate disruption, the case raises questions about the reliability of safety systems at Italian fertility clinics. Current regulations require double-checking by at least two qualified operators at each critical stage, meticulous documentation, and patient identity verification before embryo transfer. Yet this incident demonstrates that human error can still penetrate multiple safeguards.
Italy operates under Law 40/2004, which governs medically assisted reproduction and has been modified by several Constitutional Court rulings. The National Center for Transplantation (CNT) and the National Register of Assisted Reproduction at the Istituto Superiore di Sanità provide operational guidelines and collect adverse event reports.
The Technology Gap
The Italian Society of Reproduction (S.I.d.R.) has responded to the San Raffaele incident by intensifying pressure on regulators to mandate electronic witnessing systems across all fertility laboratories. These radiofrequency-based tracking platforms assign unique identifiers to every sample container and automatically halt procedures when inconsistencies are detected.
While many leading clinics already use these systems voluntarily, no national law currently requires them. Electronic witnessing technology integrates with laboratory management software to create an unbroken digital chain of custody from gamete collection through embryo transfer. Advocates argue that making these systems compulsory would eliminate the type of identification error that occurred at San Raffaele.
Legal and Ethical Dimensions
When an incorrect embryo is implanted, Italian law recognizes multiple categories of harm for which couples can seek compensation. The contractual relationship between patients and fertility clinics imposes strict obligations to maintain the integrity of genetic material and execute procedures correctly.
Affected couples have grounds to pursue damages for:
• Direct costs: Expenses incurred for the assisted reproduction cycle and future medical interventions required to address the error.
• Biological and psychological harm: Physical and emotional trauma to both partners, particularly given the intimate nature of reproductive procedures.
• Moral suffering: Deep emotional distress from violation of the most fundamental aspects of family planning and personal autonomy.
• Lost reproductive opportunity: The possibility that the error affected a couple's path to genetic parenthood through assisted reproduction.
Important Information for Expat and International Patients
For English-speaking residents and expats seeking fertility treatment in Italy, this incident highlights key safety questions to ask any clinic before treatment begins. Inquire whether the facility uses electronic witnessing systems for sample tracking and whether all staff involved in your care speak English clearly or if medical interpreters are available during critical procedures.
Be aware that Italy's public healthcare system and private fertility clinics may operate under different protocols. Ask prospective clinics to explain their specific safety procedures, how many operators verify patient identity at transfer stages, and what happens if discrepancies are detected. Request written information about these protocols in English when possible. Public facilities fall under the Ministry of Health's regulatory authority, while private clinics should also demonstrate compliance with European Directive 2004/23/EC on cells and tissues quality and safety standards.
Regulatory Oversight and Future Prevention
The Ministry of Health inspection identified protocol non-conformities at San Raffaele, though specific details have not been publicly disclosed. The facility must implement and verify corrective measures before resuming operations, with the timeline dependent on regulatory approval.
Italian fertility centers must comply with European Directive 2004/23/EC, which regulates quality and safety standards for human cells and tissues, alongside domestic legislation. Quality management systems and rigorous protocols for gamete and embryo handling are required across accredited facilities.
The CNT collaborates with the Ministry and regional health authorities to manage adverse event notifications and conduct verification programs at fertility facilities. Despite these frameworks, the San Raffaele incident suggests that compliance monitoring and human-factors training may need enhancement.
Impact on the Sector
The suspension represents a significant enforcement action against a major Italian fertility center. The San Raffaele operates one of the country's most advanced Level III assisted reproduction programs, and the temporary closure sends a clear signal about regulatory expectations for patient safety.
For couples navigating fertility treatment in Italy, the incident underscores the importance of asking detailed questions about clinic safety protocols, including whether electronic witnessing systems are in use. Patients have the right to understand what safeguards protect their genetic material at every stage and what procedures exist for error prevention and response.
The hospital's internal review will likely examine staffing levels, workload pressures, training protocols, and whether the existing quality management system adequately addressed human factors. The outcome could influence operational standards across Italy's network of approximately 360 fertility centers.
As the San Raffaele works to satisfy regulatory requirements and restore operations, the Italian healthcare system faces renewed scrutiny over whether current oversight mechanisms are sufficient to prevent errors in one of medicine's most emotionally charged fields.
